Vamos Biotech

Vamos Biotech is a bio-pharmaceutical company based in Shanghai that specializes in the development of therapies derived from insect immune systems. Founded on the pioneering research of the late Professor Sergey I. Chernysh, the company focuses on creating advanced life-cell based therapies and antimicrobial peptides to treat solid cancers, viral infections, and antibiotic-resistant bacteria. Their proprietary biosynthesis technology enables the large-scale production of unique medicinal substances like Allostatin and FLIP7, which have shown high efficacy in clinical and pre-clinical studies. The company’s product Entomix is currently registered and used as a medical solution for wound dressing and diabetic foot ulcers. Vamos Biotech operates with a global focus, aiming to provide innovative and accessible healthcare solutions for previously incurable diseases.